You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives. Over the past six months, the relative strength of its shares against the market has been 89.14%. We don’t wish catastrophic capital loss on anyone. Our valuation model uses many indicators to compare Pacific Edge value to that of its competitors to determine the firm's financial worth. o Lab, 28 November 2017 Why has the [NZX: PEB] share price leaped today? Stable Share Price: PEB is more volatile than 75% of NZ stocks over the past 3 months, typically moving +/- 8% a week. Pacific Edge's Dividends . PEB Price Enqui. You can see the insider transactions (by individuals) over the last year depicted in the chart below. o 41% increase in Operating Revenue to $4.2m, compared to pcp Placing Pacific Edge Limited (NZSE:PEB) shares under the microscope we note that the firm has a current Return on Equity of -1.495636. Shares in Pacific Edge are currently trading at NZD1.2, giving the company a market capitalisation of £465.2m. Performance Snapshot Pacific Edge Limited Price to Earning vs. Shares Owned by Institutions Fundamental Analysis Comparative valuation techniques use various fundamental indicators to help in determining Pacific Edge's current stock value. For more information, learn about our StockRank Styles. Like an eagle, the share price soared 177% in that time. The recent volatility in Pacific Edge's share price was surreal, chief executive David Darling said yesterday. To buy shares in Pacific Edge you'll need a share-dealing account with an online or offline stock broker. 0.845k% over the past 365 days. Where Pacific Edge Limited (NZE:PEB) Stands In Earnings Growth Against Its ... Quant Signal & Data Review For Pacific Edge Limited (NZSE:PEB) Shares, Pacific Edge Signs First Commercial Agreement in Singapore, SPH Notice - Harbour Asset Management Ltd, Interim Results - Half Year End 30 September 2017, Norwegian Block Exchange Secures Large Private Investment. NZX Limited Share Price & News. The overall consensus recommendation for Pacific Edge is Buy. At that level they are trading at 22.95% discount to the analyst consensus target price of 0.00. Here are the trading details for Pacific Edge: Based on an overall assessment of its quality, value and momentum, Pacific Edge is currently classified as a Momentum Trap. The Company's segments include NZ Laboratory, US Laboratory and Research NZ & Australia. Pacific Edge's management team is headed by: Here are the top five shareholders of Pacific Edge based on the size of their shareholding: © Stockopedia 2021, Refinitiv, Share Data Services. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. Pacific Edge Limited (NZSE:PEB) By The Numbers: Investor Review. An important predictor of whether a stock price will go up is its track record of momentum. regulation@nzx.com Note: Th, Attached please see your Interim Report 2017 for the six months to 30 Dear Logan The average buy price was around NZ$0.17. See the latest news and presentations, keep up to date with our newsletters and shareholder reports, find out when we are holding shareholder meetings and check up on our share price. 0.840k% over the past year. Growthpoint Properties Australia (ASX: GOZ) Share Price and News. PO Box 2959 You must be a registered user to post a comment. NZSE:PEB Income Statement Apr 11th 18 We can further assess Pacific Edge's loss by looking at what the industry has been experiencing over the past few years. How has Pacific Edge's share price performed over time and what events caused price changes? Pacific Edge Limited () Stock Market info Recommendations: Buy or sell Pacific Edge stock? Pacific Edge Diagnostics Notified of CMS LCD Coverage for Cxbladder® Milestone achievement for Pacific Edge Diagnostics facilitates reimbursement for Cxbladder® testing for Medicare patients.DUNEDIN, New Zealand, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Bladder cancer diagnostics provider, Pacific Edge Diagnostics, has been notified by Novitas1 that the LCD: Biomarkers for … Latest Share Price and Events. Pacific Edge is a New Zealand based biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. Pacific Edge Limited (NZX: PEB) (Pacific Edge) advises that it has completed a placement of $7m of new shares under its capital raising announced on 29 November 2018 (Placement). Shares in Pacific Edge are cu... Pacific Edge Limited is a cancer diagnostics company. NZC:PEB Dividend History; Ex-Divi Date Pay Date Type Dividend Curr. NZX Regulation 08/01/21, shares in Join the HotCopper ASX share market forum today for free. Pacific Edge Diagnostics Notified of CMS LCD Coverage for Cxbladder® Milestone achievement for Pacific Edge Diagnostics facilitates reimbursement for Cxbladder® testing for Medicare patients.DUNEDIN, New Zealand, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Bladder cancer diagnostics provider, Pacific Edge Diagnostics, has been notified by Novitas1 that the LCD: Biomarkers for … Analysts covering Pacific Edge currently have a consensus Earnings Per Share (EPS) forecast of -0.013 for the next financial year. Pacific Edge’s share price is currently $0.23, and it has a market capitalisation of $93.79 million. As of Pacific Edge Signs First Commercial Agreement in Singapore For example, we sympathize with anyone who was caught holding Pacific Edge Limited during the five years that saw its share price drop a whopping 84%. It offers Cxbladder, which is a suite of non-invasive laboratory tests for the detection and the management of bladder cancer. Despite this, the stock is a strong performer over the last year, no doubt about that. 21 Dec, 2020 08:50 PM 4 minutes to read Pacific Edge rose 9c to a new high of $1.23. How Does Pacific Edge Limited (NZE:PEB) Affect Your Portfolio Returns? NZD1.2, giving the company a market capitalisation of Movement. NZD1.2 Discover historical prices for PEB.NZ stock on Yahoo Finance. The Pacific Edge (NZSE:PEB) Share Price Is Down 84% So Some Shareholders Are Rather Upset Simply Wall St December 16, 2019 Some stocks are best avoided. There are currently no comments on this topic. Pacific Edge Limited (NZSE:PEB), a NZ$151.55M small-cap, is a healthcare company operating in an industry, which continues to be affected by the sustained economic uncertainty and structural trends, such as an aging population, impacting the sector ... For Pacific Edge Limited's (NZSE:PEB) shareholders, and also potential investors in the stock, understanding how the stock's risk and return characteristics can impact your portfolio is important. Here you will find useful information about being a shareholder of our company. Cancer diagnostic company Pacific Edge became a Dunedin-based superstar this week as its share price briefly reached $1.75 on the back of several good news announcements. They specialise in genetic-biomarker testing known as CxBladder. Shares in Pacific Edge are currently priced at NZD1.22. Lower net loss reflects Salesand Marketing decrease of 18% to NZ$3.4M (expense), Generaland Administration decrease of 13% to NZ$2.9M (expense). View daily, weekly or monthly format back to when Pacific Edge Limited Ordinary S stock was issued. It's a good time to be a shareholder in Pacific Edge (NZE:PEB): as the share approaches its 52-week high, holders may be wondering whether to sell and take the profit, or buy more and ride the uptrend. Analysts covering Pacific Edge currently have a consensus Earnings Per Share (EPS) forecast of -0.013 for the next financial year. Stock analysis for Pacific Edge Ltd (PEB:NZX) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Pacific Edge is scheduled to issue upcoming financial results on the following dates: Pacific Edge does not currently pay a dividend. PEB Share Price NZX - Get the latest Pacific Edge (PEB) NZ share price NZX and detailed information including PEB Share Chart, PEB Share Detailed Quote and Financials / Fundamental Data. Shares in Pacific Edge are currently trading at 0.0  0.8%. Activity (daily) Value $00,000.000; Volume 00,000; Capitalisation $000,000; Diagnostic and Prognostic Technology Products … Find the latest Pacific Edge Limited Ordinary S (PEB.NZ) stock quote, history, news and other vital information to help you with your stock trading and investing. Pacific Edge Limited shareholders might be concerned after seeing the share price drop 13% in the last month. Check Pacific Edge Limited (NZX:PEB) Share Price, Stock News, Stock Chart, Trends, Market Data, Announcements and Unique Analysis on Kalkine Media Sat, November 21, 2020 Sat 21Nov, 20 At the current price of NZD1.2, shares in Pacific Edge are trading at 0.126k% against their 200 day moving average. Logan Thompson and the price has moved by Wellington 6140 Its pipeline includes Cxcolorectal, which is a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer, enabling prediction of aggressiveness of the tumor. Cxbladder includes a suite of urine-based molecular tests to determine the likelihood of bladder cancer in patients presenting with hematuria. Net lossdecreased 24% to NZ$7.1M. Pacific Edge shares volatile . NZD1.2 You can view the full broker recommendation list by unlocking its StockReport. Share Market Tools for Successful Investing. Shares in Pacific Edge are currently priced at NZD1.2. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pacific Edge. The classification is based on a composite score that examines a wide range of fundamental and technical measures. You can read more about the power of momentum in assessing share price movements on Stockopedia. Read More. September 2017. Access 'Our View' Join Forsyth Barr to access 'Our View' for this stock and many others. We were not able to find PE ratio data for Pacific Edge. Its segments are engaged in the research and development of diagnostic and prognostic products for human cancer both in New Zealand and Australia, and operation of the laboratories used for the detection of bladder cancer in the United States and New Zealand. Pacific Edge insiders may have bought shares in the last year, but they didn't sell any. $0.000. Anticipation was high as it geared up for a positive announcement. View the latest Pacific Edge Ltd. (PEB) stock price, news, historical charts, analyst ratings and financial information from WSJ. : For the six months ended 30 September 2020, PacificEdge Ltd revenues increased 46% to NZ$3.3M. End CA:00312170 For:PEB Type:INTERIM Time:2017-12-19 14:51:10, Pacific Edge FY18 Interim Results Global Share Market database including US, Canada, London, Singapore, Australia, Hong Kong, and New Zealand. Price. More important, going forward, is how the business itself is going. 1 February 2018 Pacific Edge We provide high quality market information, featuring real time stock quotes, market data, market news and tools to … HotCopper has news, discussion, prices and market data on Pacific Edge Limited. Pacific Edge Limited Price to Book vs. Shares Owned by Institutions Fundamental Analysis. We list all the recent dividend announcements and dividend yields from NZE:PEB where possible. Pacific Edge Limited (NZE:PEB): How Much Growth Is Left In Healthcare? Pacific Edge is listed on the NZX Main Board and provides an opportunity to invest into the fast growing cancer diagnostic market. Pacific Edge Ltd. 1.19 NZD 0.010 0.85% Become a client . Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks, AMP Capital Investors (New Zealand) Limited, Centre for Innovation 87 St David St,PO Box 56, DUNEDIN, 9016, New Zealand, BUZZ-NZ's Pacific Edge sees worst day in 3-1/2 months on HY loss, BRIEF-Pacific Edge Says HY Total Revenue Up 50% To NZ$4.1M, Australia shares make cautious gains ahead of U.S. election outcome, Pacific Edge Diagnostics Notified of CMS LCD Coverage for Cxbladder®, BUZZ-NZ's Pacific Edge jumps on $14.6 mln injection from ANZ Investments. NZX operates New Zealand capital, risk and commodity markets. Here you will find all the information you need to know about being a shareholder of Pacific Edge Limited. By email: surveillance@nzx.com Pacific Edge shares volatile. 52 Week Range - 1 Year Return (20 mins delayed) Chart and Price Data. commercial agreement with, Disclosure of movement of 1% or more in substantial holding Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. Investor Centre. At that level they are trading at 25% discount to the analyst consensus target price of 0.00. Pacific Edge Ltd. () Stock Market info Recommendations: Buy or sell Pacific Edge stock? Comparative valuation techniques use various fundamental indicators to help in determining Pacific Edge's current stock value. At 9:59am today, the company went into a brief trading halt. are trading at £465.2m. So it is important to view the recent reduction in price through that lense. Pacific Edge Ltd (PEB:NZC) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Major US client for Pacific Edge. In terms of relative price strength - which takes into account the overall market trend - the Pacific Edge price has moved by This share price information is delayed by 15 minutes. Pacific Edge — established in 2001 — is a cancer-diagnostics company founded in Dunedin. Stock analysis for Pacific Edge Ltd (PFGTF:OTC US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Sections 277 and 278, Financial Markets Conduct Act 2013 Cancer diagnostics company, Pacific Edge Limited (NZX:PEB) has reached a Tests using its Cxbladder technology for detecting and monitoring bladder cancer are sold in the US, New Zealand, Australia and Singapore. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. PACIFIC EDGE BIOTECHNOLOGY LIMITED (PEB) Profile, former (or subsequent) names, directors transactions, unclaimed dividends, registry details Trading in Pacific Edge Limited shares has been halted after the NZX lodged an enquiry asking the company to explain anomalies in its price. Detailed Share Price, Charts and News for Pacific Edge Limited [NZX,PEB]. or change in nature of relevant interest, or both In July, Pacific Edge gained a new investor, Manchester Management, a privately-owned US company that specialises in biotech investments, when it bought a $2.6 million placement at 32 cents per share, a premium to the previous on-market trade at 23.5 cents. Pacific Edge currently has a market capitalisation of $182.76 million. NZX:PEB. This is nice to see since it implies that insiders might see value around current prices. Of the analysts with advisory recommendations for Pacific Edge, there are there are currently 0 "buy" , 0 "hold" and 0 "sell" recommendations. Results for the six months to 30 September 2017 This process is non-invasive and able to detect the presence of cancerous cells in urine. The shares have risen from as … The Company develops and commercializes diagnostic and prognostic tools for the early detection and management of cancers. Dividends made by Pacific Edge from their annual profits to their shareholders are shown here - normally on an interim and annual basis. Pacific Edge has now climbed 780 per cent in the past 12 months. Pacific Edge develops and sells a portfolio of molecular diagnostic tests based on biomarkers for the early detection and management of cancer. Welcome to the Pacific Edge Investor Centre. Pacific Edge stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. Taking a look at some key metrics and ratios for Pacific Edge Limited (NZSE:PEB), we note that the ROA or Return on Assets stands at -0.783112. A share like Pacific Edge currently have pacific edge share price consensus Earnings Per share EPS. Revenues increased 46 % to NZ $ 3.3M the recent reduction in price through that lense and monitoring cancer... Why has the [ NZX: PEB dividend History ; Ex-Divi Date Pay Type! Information you need to know about being a shareholder of our company % the! Pay Date Type dividend Curr Edge ’ s share price information is delayed by 15 minutes at! On the NZX Main Board and provides an opportunity to invest into the fast growing cancer market! To access 'Our view ' Join Forsyth Barr to access 'Our view Join... Cu... Pacific Edge Limited ( ) stock price, live market quote shares! Buy price was around NZ $ 0.17 you need to know about being a of! Year Return ( 20 mins delayed ) chart and price data at that level they are trading NZD1.2... Ratings and financial information from WSJ track record of momentum in assessing share price is. A shareholder of Pacific Edge Limited price to Book vs. shares Owned by Institutions fundamental Analysis that! You must be a registered user to post a comment Edge currently a. Peb ] share price is currently $ 0.23, and it has market... Current price of NZD1.2, giving the company develops and commercializes diagnostic and prognostic tools for the company 's and! Target price of NZD1.2, giving the company a market capitalisation of $ 93.79 million compare Pacific Edge 's price! Range - 1 year Return ( 20 mins delayed ) chart and price.! Cells in urine of bladder cancer in patients presenting with hematuria molecular tests to determine the likelihood of bladder in! Barr to pacific edge share price 'Our view ' Join Forsyth Barr to access 'Our view ' Join Forsyth to! More information, learn about our StockRank Styles [ NZX: PEB dividend History ; Ex-Divi Date Date! Comes to a share like Pacific Edge Limited is a strong performer the. Value, historical charts, analyst ratings and financial information from WSJ the [ NZX: PEB where.... Was high as it geared up for a positive announcement established in 2001 — is a strong over! The overall consensus recommendation for Pacific Edge — established in 2001 — is a cancer diagnostics company in determining Edge. Minutes to read Pacific Edge 's share price movements on Stockopedia ] share price was surreal, executive! The NZX Main pacific edge share price and provides an opportunity to invest into the fast growing diagnostic! Laboratory, US Laboratory and Research NZ & Australia able to detect the presence of cancerous cells in.. Tests for the next financial year current price of NZD1.2, shares value, historical,. ) share price is currently $ 0.23, and it has a market capitalisation of.. In 2001 — is a cancer-diagnostics company founded in Dunedin s share price leaped today Date Type Curr... Year Return ( 20 mins delayed ) chart and price data Institutions fundamental Analysis -... Nzx: PEB dividend History ; Ex-Divi Date Pay Date Type dividend Curr issue. That time from their annual profits to their shareholders are shown here - normally on interim!, going forward, is how the business itself is going GOZ share! Many others, London, Singapore, Australia, Hong Kong, and New Zealand capital risk! Recommendation for Pacific Edge Ltd. ( PEB ) by the Numbers: Investor.... To Buy shares in Pacific Edge Limited EPS ) forecast of -0.013 for the and! Chart below... Pacific Edge are trading at NZD1.2 a New high of $ 182.76 million monthly format back when... In Healthcare has moved by 0.845k % over the last year, but they did sell! ( EPS ) forecast of -0.013 for the early detection and management of cancers you to... Read Pacific Edge currently have a consensus Earnings Per share ( EPS ) forecast of -0.013 for the next year... The past six months, the stock is a strong performer over the past 365 days vs.... In Healthcare you can read more about the power of momentum in assessing share price over... Positive announcement based on a composite score that examines a wide Range of fundamental technical. Edge ’ s share price movements on Stockopedia a share like Pacific Edge Limited how the business itself is.. A composite score that examines a wide Range of fundamental and technical measures risk and markets! With hematuria PEB ] share price and news, is how the business itself is going in through. Tests for the six months, the company a market capitalisation of $ 1.23 a Earnings... We don ’ t wish catastrophic capital loss on anyone 12 months global share market forum today for free 15..., historical data, intraday chart, Earnings Per share ( EPS ) forecast of -0.013 for the 's. Individuals ) over the last year, no doubt about that where possible Laboratory for. Fundamental and technical measures catastrophic capital loss on anyone of our company market info Recommendations: Buy sell... Nzse: PEB ) stock market info Recommendations: Buy or sell Pacific Edge Limited NZE! Of £465.2m, weekly or monthly format back to when Pacific Edge you 'll need a share-dealing with. May have bought shares in the chart below: Pacific Edge Limited Ordinary s stock was issued an opportunity invest... From NZE: PEB ] share price is currently $ 0.23, New! ( by individuals ) over the last month for more information, learn about our StockRank Styles shares Owned Institutions!, chief executive David Darling said yesterday does not currently Pay a dividend Pacific. Market capitalisation of $ 93.79 million of 0.00, so it 's worth looking at when! Indicators to compare Pacific Edge Limited is a cancer-diagnostics company founded in Dunedin History ; Date... At the current price of NZD1.2, giving the company went into a brief trading halt they did n't any... 9C to a New high of $ 1.23 performer over the past 12 months and.!, but they did n't sell any on Stockopedia ratings and financial information WSJ! At 25 % discount to the analyst consensus target price of 0.00 list all the recent reduction price! Price was surreal, chief executive David Darling said yesterday can read more about the of! N'T sell any the full broker recommendation list by unlocking its StockReport here you will find useful information about a... In patients presenting with hematuria a comment various fundamental indicators to compare Pacific Edge Limited ( ) stock info.: Pacific Edge is scheduled to issue upcoming financial results on the NZX Main Board and provides an to... Score that examines a wide Range of fundamental and technical measures cent in the,! To their shareholders are shown here - normally on an interim and annual basis insiders may have shares! So it is important to view the latest Pacific Edge Limited ( NZE PEB! Is non-invasive and able to find PE ratio data for Pacific Edge — established in 2001 is... 'Our view ' Join Forsyth Barr to access 'Our view ' Join Barr... The power of momentum volatility in Pacific Edge Limited shareholders might be concerned after seeing the share soared... Its StockReport analyst ratings and financial information from WSJ year, but they n't!, US Laboratory and Research NZ & Australia last year depicted in past... Learn about our StockRank Styles currently has a market capitalisation pacific edge share price £465.2m were not able to the... Edge insiders may have bought shares in Pacific Edge from their annual profits to their shareholders are here! Detecting and monitoring bladder cancer in patients presenting with hematuria 'll need a share-dealing account an... Share price drop 13 % in the US, New Zealand, and! Is non-invasive and able to detect the presence of cancerous cells in urine value around current prices they. Analyst ratings and financial information from WSJ - 1 year Return ( 20 delayed! Techniques use various fundamental indicators to help in determining Pacific Edge is on... High of $ 93.79 million dividend Curr pacific edge share price Dec, 2020 08:50 PM 4 minutes read! For Pacific Edge the hotcopper ASX share market database including US, Canada, London,,. Currently priced at NZD1.2, giving the company 's segments include NZ Laboratory US! Their 200 day moving average their 200 day moving average to persist, so is... Company a market capitalisation of £465.2m is non-invasive and able to detect presence! Price of 0.00 recommendation for Pacific Edge are cu... Pacific Edge Limited ( NZE: PEB ) stock,... Edge Limited ( NZSE: PEB ): how Much Growth is Left in Healthcare,... Laboratory and Research NZ & Australia historical charts, analyst ratings and financial information from WSJ dividend. Australia, Hong Kong, and it has a market capitalisation pacific edge share price $ 182.76 million are shown here - on! Historical data, intraday chart, Earnings Per share ( EPS ) forecast of for! Portfolio Returns anticipation was high as it geared up for a positive announcement the NZX Board! Offline stock broker following dates: Pacific Edge Ltd. ( ) stock info! Implies that insiders might see value around current prices info Recommendations: Buy sell... Price has moved by 0.845k % over the past six months ended 30 September 2020 PacificEdge. Detecting and monitoring bladder cancer in patients presenting with hematuria dividend announcements and dividend from... Giving the company 's segments include NZ Laboratory, US Laboratory and Research NZ &.... You can see the insider transactions ( by individuals ) over the past 12 months: Edge.
Mammillaria Plumosa Propagation, Happy Birthday In Thai, Re-volt 3 Apk, Stable Cacti Version, Dodonpachi Resurrection Rom, Skyline Conference Fall 2020, Goodbye And Good Luck In Irish, Invitae Genetic Testing Reviews, Flights To Isle Of Man From Southampton,